PhD – Director, AIEthicsLab
Cansu is a philosopher and the founder/director of the AI Ethics Lab, where she leads teams of computer scientists and legal scholars to provide ethics analysis and guidance to researchers and practitioners.
She has a Ph.D. in philosophy specializing in applied ethics. She works on ethics of technology and population-level bioethics with an interest in policy questions. Prior to the AI Ethics Lab, she was a lecturer at the University of Hong Kong, and a researcher at the Harvard Law School, Harvard School of Public Health, Harvard Medical School, National University of Singapore, Osaka University, and the World Health Organization. She tweets @ccansu.
AREAS OF INTEREST – Applied Ethics (focusing on Ethics of Technology and Population-Level Bioethics), Moral and Political Philosophy
PUBLISHED WORKS & WORKS IN PROGRESS – “A User-Focused Transdisciplinary Research Agenda for AI-Enabled Health Tech Governance,” co-authored with D. Arney, M. Senges, S. Gerke, L. H. Ihle, N. Kaiser, S. Kakarmath, A. Kupke, A. Gajeele, S. Lynch, L. Melendez, Harvard University Berkman Klein Center for Internet & Society, Working Paper, Winter 2019.
“On Coercive Offers: In Support of a Market in Kidneys,” International Journal of Applied Philosophy, Volume 31, Issue 2, Fall 2017, doi: 10.5840/ijap201822791.
“The Unjustified Policy Against a Market in Kidneys,” Asian Bioethics Review, Volume 8, Issue 3, 2016, doi: 10.1353/ asb.2016.0016.
“White Christmas and Technological Restraining Orders: Are Digital Blocks Ethical?,” co-authored with L. H. Ihle, Black Mirror and Philosophy, ed. W. Irwin and D. K. Johnson, Wiley-Blackwell (upcoming)
“What Should Kant Have Said? A Kantian Argument against the Prohibition of a Kidney Market” (under review)
“IRBs / RECs for AI: An Unintelligent Choice” (draft available)
“Machine Learning in Healthcare and Its Effects on Clinical Research”
“Watching the White Swan Bleed: What is Wrong with Ballet?”
“Gamer’s World: Virtual Reality and Personal Data”